Evidence map›Paper›PMID 32727358›Full record

ArticleBMC microbiology2020

Screening and identification of BP100 peptide conjugates active against Xylella fastidiosa using a viability-qPCR method.

Aina Baró, Esther Badosa, Laura Montesinos, Lidia Feliu, Marta Planas, Emilio Montesinos, Anna Bonaterra

Open access · goldAbstract read
In one paragraph

Article in BMC microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 33 citations in OpenAlex.

  1. Review
  2. Article
  3. Synergistic Biocontrol ofInternational journal of molecular sciences · 2025
    Article
  4. Chemical Treatments Tested AgainstPathogens (Basel, Switzerland) · 2025
    Review
  5. Article
  6. Review
  7. Preliminary transcriptomic analyses revealFrontiers in microbiology · 2025
    Article
  8. Article
  9. Article
  10. Synergistic antibacterial activity ofFrontiers in microbiology · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Thidiazuron: New Trends and Future Perspectives to FightAntibiotics (Basel, Switzerland) · 2022
    Review
  17. Article
  18. Microorganisms · 2021
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Aina BaróLaboratory of Plant Pathology, Institute of Food and Agricultural Technology-CIDSAV-XaRTA, University of Girona, Girona, Spain.
Esther BadosaLaboratory of Plant Pathology, Institute of Food and Agricultural Technology-CIDSAV-XaRTA, University of Girona, Girona, Spain.
Laura MontesinosLaboratory of Plant Pathology, Institute of Food and Agricultural Technology-CIDSAV-XaRTA, University of Girona, Girona, Spain.
Lidia FeliuLIPPSO, Department of Chemistry, University of Girona, Girona, Spain.
Marta PlanasLIPPSO, Department of Chemistry, University of Girona, Girona, Spain.
Emilio MontesinosLaboratory of Plant Pathology, Institute of Food and Agricultural Technology-CIDSAV-XaRTA, University of Girona, Girona, Spain.
Anna BonaterraLaboratory of Plant Pathology, Institute of Food and Agricultural Technology-CIDSAV-XaRTA, University of Girona, Girona, Spain. anna.bonaterra@udg.edu.ORCID 0000-0002-6755-5313
Universitat de Girona · ES

Funding

AUTOIMMUNE MECHANISMS IN GLAUCOMATOUS OPTIC NEUROPATHYK11EY000334 · NEI · WASHINGTON UNIVERSITY · PI BARRETT, DEBRA A · 1994 to 1994
–
H2020 European Research Council XF-ACTORS cod. 727987Ministerio de Ciencia, Innovación y Universidades E-RTA INIA 2017-00004-C06-03Ministerio de Ciencia, Innovación y Universidades RTI2018-099410-B-C21Organización Interprofesional del Aceite de Oliva Español 041/18Secretaria d'Universitats i Recerca, Departament d'Economia i Coneixement, Generalitat de Catalunya, Spain 2018 FI B00334
6 · The paper itself

Abstract

backgroundXylella fastidiosa is one of the most harmful bacterial plant pathogens worldwide, causing a variety of diseases, with huge economic impact to agriculture and environment. Although it has been extensively studied, there are no therapeutic solutions to suppress disease development in infected plants. In this context, antimicrobial peptides represent promising alternatives to traditional compounds due to their activity against a wide range of plant pathogens, their low cytotoxicity, their mode of action that make resistance more difficult and their availability for being expressed in plants.

resultsPeptide conjugates derived from the lead peptide BP100 and fragments of cecropin, magainin or melittin were selected and tested against the plant pathogenic bacteria X. fastidiosa. In order to screen the activity of these antimicrobials, and due to the fastidious nature of the pathogen, a methodology consisting of a contact test coupled with the viability-quantitative PCR (v-qPCR) method was developed. The nucleic acid-binding dye PEMAX was used to selectively quantify viable cells by v-qPCR. In addition, the primer set XF16S-3 amplifying a 279 bp fragment was selected as the most suitable for v-qPCR. The performance of the method was assessed by comparing v-qPCR viable cells estimation with conventional qPCR and plate counting. When cells were treated with peptide conjugates derived from BP100, the observed differences between methods suggested that, in addition to cell death due to the lytic effect of the peptides, there was an induction of the viable but non-culturable state in cells. Notably, a contact test coupled to v-qPCR allowed fast and accurate screening of antimicrobial peptides, and led to the identification of new peptide conjugates active against X. fastidiosa.

conclusionsAntimicrobial peptides active against X. fastidiosa have been identified using an optimized methodology that quantifies viable cells without a cultivation stage, avoiding underestimation or false negative detection of the pathogen due to the viable but non-culturable state, and overestimation of the viable population observed using qPCR. These findings provide new alternative compounds for being tested in planta for the control of X. fastidiosa, and a methodology that enables the fast screening of a large amount of antimicrobials against this plant pathogenic bacterium.

Indexed as

Anti-Bacterial AgentsAntimicrobial Cationic PeptidesMicrobial Sensitivity TestsMicrobial ViabilityOligopeptidesPeptide FragmentsPlant DiseasesReal-Time Polymerase Chain ReactionXylellaAnti-Bacterial AgentsAntimicrobial Cationic Peptideslysyl-lysyl-leucyl-phenylalanyl-lysyl-lysyl-isoleucyl-leucyl-lysyl-tyrosyl-leucinamideOligopeptidesPeptide FragmentsAntimicrobial peptidesPEMAXPlant pathogensViability-qPCRXylella fastidiosa

Identifiers

PMID32727358
PMCPMC7392676
OpenAlexW3046099519

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.